CSF Profile in Autoimmune Encephalitis
The typical CSF profile in autoimmune encephalitis shows mild to moderate lymphocytic pleocytosis (20-200 cells/mm³), elevated protein, and often positive oligoclonal bands, but critically, routine CSF parameters can be completely normal in 12-27% of cases, which should never exclude the diagnosis when clinical suspicion is high. 1
Core CSF Findings
Common abnormalities include:
- Lymphocytic pleocytosis: Typically 20-200 cells/mm³, though can range from 0 to as high as 900 cells/mm³ depending on antibody type 1
- Elevated protein (hyperproteinorrachia): Present in approximately 60.6% of cases 2
- Intrathecal oligoclonal bands: Found in 45.4% of patients (unmatched in serum) 2
- Elevated IgG index and/or IgG synthesis rate: Present in some cases 1
Critical Pitfall: Normal CSF Does Not Exclude AE
A substantial proportion of patients with confirmed autoimmune encephalitis have completely normal routine CSF studies:
- 27% of AE patients have normal CSF white blood cell counts and protein levels 3
- 14% have entirely "normal" CSF even when oligoclonal banding is included 3
- 12.1% show no abnormalities in routine CSF parameters at diagnosis 2
This is particularly important because normal CSF can delay diagnosis if antibody testing is not performed. 2 The guideline explicitly states that routine CSF studies may be normal in some AE patients and this does not exclude the diagnosis when other parameters are consistent with AE. 1
Antibody-Specific Variations
CSF sensitivity varies by antibody type:
- CSF testing is more sensitive for NMDAR and GFAP antibodies 1
- Serum testing is more sensitive for onconeuronal, LGI1, and AQP4 antibodies 1
- NMDAR encephalitis tends to show higher CSF white cell counts compared to other subtypes 4
- Non-NMDAR subtypes more commonly show elevated protein 4
Comprehensive CSF Analysis Required
The guideline recommends the following complete CSF workup: 1
- Cell count and differential
- Protein and glucose levels
- CSF/serum glucose ratio
- Albumin quotient
- IgG index and synthesis rate
- Oligoclonal bands
- Broad viral studies (HSV1/2 PCR, VZV PCR and IgG/IgM)
- Bacterial/fungal cultures when appropriate
- Cytology and flow cytometry
- Neuronal autoantibody (NAA) panel - mandatory even with normal routine CSF 1
Prognostic Value of CSF Findings
Specific CSF parameters correlate with treatment response and severity:
- CSF WBC >5 cells/mm³ associates with treatment failure (OR 16.0) 4
- CSF WBC >20 cells/mm³ associates with ICU admission (OR 19.3) 4
- Positive IgG local synthesis strongly predicts good rapid treatment response (adjusted OR 28.71) 5
- CSF WBC >4 cells/mm³ associates with good rapid treatment response (OR 4.57) 5
Timing Considerations
CSF findings evolve over the disease course:
- Repeated CSF analyses show a trend toward normalization of initially pathological findings 2
- Relapses are more likely associated with increased cell counts and total protein levels 2
- Oligoclonal band status conversion in anti-NMDAR patients may coincide with clinical improvement 2
Clinical Action Points
When CSF is normal but clinical suspicion remains high:
- Proceed with NAA panel testing in both CSF and serum - this is non-negotiable 1
- Do not delay empiric immunotherapy if inflammatory CSF is the only abnormality after excluding infection 1
- Inflammatory CSF alone can serve as the sole indication for empiric immunotherapy after infection is excluded 1
The absence of CSF pleocytosis should never delay treatment initiation in patients with suspected autoimmune encephalitis based on clinical presentation and other supportive findings. 1, 6